Style | Citing Format |
---|---|
MLA | Mahmoudnejad N, et al.. "Achieving a One-Year-Tumor-Free Survival in a Female With Primary Large Cell Neuroendocrine Carcinoma of the Urinary Bladder and Liver Metastasis; a Case Report." Urology Case Reports, vol. 47, no. , 2023, pp. -. |
APA | Mahmoudnejad N, Mohammadi Torbati P, Lashay A, Ahmadi N, Guitynavard F (2023). Achieving a One-Year-Tumor-Free Survival in a Female With Primary Large Cell Neuroendocrine Carcinoma of the Urinary Bladder and Liver Metastasis; a Case Report. Urology Case Reports, 47(), -. |
Chicago | Mahmoudnejad N, Mohammadi Torbati P, Lashay A, Ahmadi N, Guitynavard F. "Achieving a One-Year-Tumor-Free Survival in a Female With Primary Large Cell Neuroendocrine Carcinoma of the Urinary Bladder and Liver Metastasis; a Case Report." Urology Case Reports 47, no. (2023): -. |
Harvard | Mahmoudnejad N et al. (2023) 'Achieving a One-Year-Tumor-Free Survival in a Female With Primary Large Cell Neuroendocrine Carcinoma of the Urinary Bladder and Liver Metastasis; a Case Report', Urology Case Reports, 47(), pp. -. |
Vancouver | Mahmoudnejad N, Mohammadi Torbati P, Lashay A, Ahmadi N, Guitynavard F. Achieving a One-Year-Tumor-Free Survival in a Female With Primary Large Cell Neuroendocrine Carcinoma of the Urinary Bladder and Liver Metastasis; a Case Report. Urology Case Reports. 2023;47():-. |
BibTex | @article{ author = {Mahmoudnejad N and Mohammadi Torbati P and Lashay A and Ahmadi N and Guitynavard F}, title = {Achieving a One-Year-Tumor-Free Survival in a Female With Primary Large Cell Neuroendocrine Carcinoma of the Urinary Bladder and Liver Metastasis; a Case Report}, journal = {Urology Case Reports}, volume = {47}, number = {}, pages = {-}, year = {2023} } |
RIS | TY - JOUR AU - Mahmoudnejad N AU - Mohammadi Torbati P AU - Lashay A AU - Ahmadi N AU - Guitynavard F TI - Achieving a One-Year-Tumor-Free Survival in a Female With Primary Large Cell Neuroendocrine Carcinoma of the Urinary Bladder and Liver Metastasis; a Case Report JO - Urology Case Reports VL - 47 IS - SP - EP - PY - 2023 ER - |